Agamree (vamorolone)

Agamree (vamorolone) is a prescription medicine indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and up.

Agamree is approved by the FDA in the USA.

  • Disease Indications : Duchenne Muscular Dystrophy
  • Usage : Oral
Medicine approved by
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)